63 related articles for article (PubMed ID: 11775111)
1. Prophylactic efficacy of recombinant IL-12, clindamycin alone or in combination against experimental reactivated toxoplasmosis.
Tawfeek GM; Oteifa NM; Mustafa MA
J Egypt Soc Parasitol; 2001 Dec; 31(3):853-66. PubMed ID: 11775111
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
Gamra MM; el-Hosseiny LM
J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
[TBL] [Abstract][Full Text] [Related]
3. Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis.
Araujo FG; Hunter CA; Remington JS
Antimicrob Agents Chemother; 1997 Jan; 41(1):188-90. PubMed ID: 8980778
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii.
Djurković-Djaković O; Milenković V; Nikolić A; Bobić B; Grujić J
J Antimicrob Chemother; 2002 Dec; 50(6):981-7. PubMed ID: 12461021
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.
Gazzinelli R; Xu Y; Hieny S; Cheever A; Sher A
J Immunol; 1992 Jul; 149(1):175-80. PubMed ID: 1351500
[TBL] [Abstract][Full Text] [Related]
6. Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis.
Israelski D; Remington J
Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):358-60. PubMed ID: 2115442
[TBL] [Abstract][Full Text] [Related]
7. Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii.
Benedetto N; Auriault C; Darcy F; Lando D; Watier H; Capron A
Eur Cytokine Netw; 1991; 2(2):107-14. PubMed ID: 1813013
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of rIL-12 synergistically enhances the therapeutic effect of a TNF gene-transduced cancer vaccine.
Taniguchi F; Yamagishi H; Fujiwara H; Ueda Y; Fuji N; Yoshimura T; Oka T
Gene Ther; 1998 Dec; 5(12):1677-84. PubMed ID: 10023447
[TBL] [Abstract][Full Text] [Related]
9. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
Hunter CA; Chizzonite R; Remington JS
J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
[TBL] [Abstract][Full Text] [Related]
10. [Effects of clindamycin and josamycin in experimental Toxoplasma gondii infections].
Terragna A; Canessa A; Terragna FM; Corradino L
Minerva Med; 1984 Oct; 75(39):2305-8. PubMed ID: 6504394
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection.
Ely KH; Kasper LH; Khan IA
J Immunol; 1999 May; 162(9):5449-54. PubMed ID: 10228024
[TBL] [Abstract][Full Text] [Related]
12. Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.
Araujo FG
J Immunol; 1992 Nov; 149(9):3003-7. PubMed ID: 1357033
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production.
Puliti M; von Hunolstein C; Bistoni F; Mosci P; Orefici G; Tissi L
Arthritis Rheum; 2002 Mar; 46(3):806-17. PubMed ID: 11920419
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.
Kawakami K; Hossain Qureshi M; Zhang T; Koguchi Y; Xie Q; Kurimoto M; Saito A
Cell Immunol; 1999 Oct; 197(1):55-61. PubMed ID: 10555996
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
[TBL] [Abstract][Full Text] [Related]
16. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.
Khan IA; Kasper LH
J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis.
Hunter CA; Roberts CW; Alexander J
Eur J Immunol; 1992 Sep; 22(9):2317-22. PubMed ID: 1516621
[TBL] [Abstract][Full Text] [Related]
18. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
Khan IA; Matsuura T; Fonseka S; Kasper LH
J Immunol; 1996 Jan; 156(2):636-43. PubMed ID: 8543815
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice.
Clemons KV; Lutz JE; Stevens DA
Antimicrob Agents Chemother; 2001 Mar; 45(3):686-9. PubMed ID: 11181343
[TBL] [Abstract][Full Text] [Related]
20. Treatment protocol determines the efficacy of clindamycin in acute murine toxoplasmosis.
Nikolić T; Djurković-Djaković O; Bobić B; Nikolić A; Babić D
Int J Antimicrob Agents; 1999 Feb; 11(2):145-9. PubMed ID: 10221418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
